Brady James Aloysius bought XERS
June 4, 2026 · Form 4 insider transaction
Brady James Aloysius bought 32,996 shares of Xeris Biopharma Holdings, Inc. at $6.15 per share, a transaction worth $202.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
32,996
Price
$6.15
Total value
$202.9K
InsiderBrady James Aloysius
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 5, 2026
Shares owned after32,996
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date.